Ryu Watanabe (R Watanabe)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 26

Top Venues

Journal of clinical medicine

Annals of the rheumatic diseases

International journal of molecular sciences

Biomolecules

Osaki Citizen Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Osaki Citizen Hospital

Japan

副科長

Stanford University

United States

Visiting Assistant Professor :: Medicien

Tohoku University

Japan

助教

Publications

Mayu Shiomi, Ryu Watanabe, Shogo Matsuda, Takuya Kotani, Ayana Okazaki, Yuichi Masuda, Tsuneyasu Yoshida, Mikihito Shoji, Ryosuke Tsuge, Keiichiro Kadoba, Ryosuke Hiwa, Wataru Yamamoto, Akitoshi Takeda, Yoshiaki Itoh, Motomu Hashimoto
Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort study. Modern rheumatology (2024)
Ryuhei Ishihara, Ryu Watanabe, Mayu Shiomi, Masao Katsushima, Kazuo Fukumoto, Shinsuke Yamada, Tadashi Okano, Motomu Hashimoto
Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine. Biomolecules 14 (7) (2024)
Ryuhei Ishihara, Ryu Watanabe, Mayu Shiomi, Masao Katsushima, Kazuo Fukumoto, Shinsuke Yamada, Tadashi Okano, Motomu Hashimoto
Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine. Biomolecules 14 (7) (2024)
Ryuhei Ishihara, Ryu Watanabe, Mayu Shiomi, Masao Katsushima, Kazuo Fukumoto, Shinsuke Yamada, Tadashi Okano, Motomu Hashimoto
Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine. Biomolecules 14 (7) (2024)
Quang Minh Dang, Ryu Watanabe, Mayu Shiomi, Kazuo Fukumoto, Tomomi W Nobashi, Tadashi Okano, Shinsuke Yamada, Motomu Hashimoto
Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors-A 2023 Update. International journal of molecular sciences 24 (6) (2023)
Ryu Watanabe, Keiichiro Kadoba, Atsuko Tamamoto, Koichi Murata, Kosaku Murakami, Hideo Onizawa, Takayuki Fujii, Akira Onishi, Masao Tanaka, Hiromu Ito, Akio Morinobu, Motomu Hashimoto
CD8 + Regulatory T Cell Deficiency in Elderly-Onset Rheumatoid Arthritis. Journal of clinical medicine 12 (6) (2023)
Ryu Watanabe, Motomu Hashimoto
Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations. Journal of clinical medicine 12 (18) (2023)
Ryu Watanabe, Kosaku Murakami, Toshimitsu Fujisaki, Hiromu Ito, Koichi Murata, Wataru Yamamoto, Takayuki Fujii, Hideo Onizawa, Akira Onishi, Masao Tanaka, Akio Morinobu, Motomu Hashimoto
Baseline erythrocyte sedimentation rate level predicts long-term inhibition of radiographic progression by tocilizumab: the KURAMA cohort. Immunological medicine (2023)
Quang Minh Dang, Ryu Watanabe, Mayu Shiomi, Kazuo Fukumoto, Tomomi W Nobashi, Tadashi Okano, Shinsuke Yamada, Motomu Hashimoto
Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors-A 2023 Update. International journal of molecular sciences 24 (6) (2023)
Quang Minh Dang, Ryu Watanabe, Mayu Shiomi, Kazuo Fukumoto, Tomomi W Nobashi, Tadashi Okano, Shinsuke Yamada, Motomu Hashimoto
Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors-A 2023 Update. International journal of molecular sciences 24 (6) (2023)
Ryu Watanabe, Keiichiro Kadoba, Atsuko Tamamoto, Koichi Murata, Kosaku Murakami, Hideo Onizawa, Takayuki Fujii, Akira Onishi, Masao Tanaka, Hiromu Ito, Akio Morinobu, Motomu Hashimoto
CD8 + Regulatory T Cell Deficiency in Elderly-Onset Rheumatoid Arthritis. Journal of clinical medicine 12 (6) (2023)
Ryu Watanabe, Keiichiro Kadoba, Atsuko Tamamoto, Koichi Murata, Kosaku Murakami, Hideo Onizawa, Takayuki Fujii, Akira Onishi, Masao Tanaka, Hiromu Ito, Akio Morinobu, Motomu Hashimoto
CD8 + Regulatory T Cell Deficiency in Elderly-Onset Rheumatoid Arthritis. Journal of clinical medicine 12 (6) (2023)
Ryu Watanabe, Motomu Hashimoto
Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis. Rheumatology (Oxford, England) 61 (7) (2022)
Yoichi Nakayama, Ryu Watanabe, Kosaku Murakami, Koichi Murata, Masao Tanaka, Hiromu Ito, Wataru Yamamoto, Kosuke Ebina, Kenichiro Hata, Yuri Hiramatsu, Masaki Katayama, Yonsu Son, Hideki Amuro, Kengo Akashi, Akira Onishi, Ryota Hara, Keiichi Yamamoto, Koichiro Ohmura, Shuichi Matsuda, Akio Morinobu, Motomu Hashimoto
Differential efficacy of TNF inhibitors with or without the immunoglobulin fragment crystallizable (Fc) portion in rheumatoid arthritis: the ANSWER cohort study. Rheumatology international 42 (7) (2022)
Y Ishihama, Kazuo Fukumoto, Ryu Watanabe, S Nakatani, A Tsuda, T Otoshi, K Yamada, S Yamada, N Negoro, M Emoto, Motomu Hashimoto
Retroperitoneal fibrosis requiring prompt nephrostomy in a case with immunoglobulin A vasculitis. Scandinavian journal of rheumatology 51 (5) (2022)
Kohei Doi, Koichi Murata, Shuji Ito, Akari Suzuki, Chikashi Terao, Shinichiro Ishie, Akio Umemoto, Yoshiki Murotani, Kohei Nishitani, Hiroyuki Yoshitomi, Takayuki Fujii, Ryu Watanabe, Motomu Hashimoto, Kosaku Murakami, Masao Tanaka, Hiromu Ito, Kyung-Hyun Park-Min, Lionel B Ivashkiv, Akio Morinobu, Shuichi Matsuda
Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1. Arthritis & rheumatology (Hoboken, N.J.) 74 (6) (2022)
Eriho Yamaguchi, Keiichiro Kadoba, Ryu Watanabe, Takeshi Iwasaki, Koji Kitagori, Shuji Akizuki, Kosaku Murakami, Ran Nakashima, Motomu Hashimoto, Masao Tanaka, Akio Morinobu, Hajime Yoshifuji
Clinical Profile and Outcome of Large-Vessel Giant Cell Arteritis in Japanese Patients: A Single-Center Retrospective Cohort Study. Modern rheumatology (2022)
Tomoya Nakajima, Ryu Watanabe, Motomu Hashimoto, Koichi Murata, Kosaku Murakami, Masao Tanaka, Hiromu Ito, Wataru Yamamoto, Koji Kitagori, Shuji Akizuki, Ran Nakashima, Hajime Yoshifuji, Koichiro Ohmura, Shuichi Matsuda, Akio Morinobu
Neutrophil count reduction 1 month after initiating tocilizumab can predict clinical remission within 1 year in rheumatoid arthritis patients. Rheumatology international (2021)
Ryu Watanabe, Motomu Hashimoto, Koichi Murata, Kosaku Murakami, Masao Tanaka, Koichiro Ohmura, Hiromu Ito, Shuichi Matsuda
Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort. Immunological medicine (2021)
Tamami Yoshida, Motomu Hashimoto, Go Horiguchi, Kosaku Murakami, Koichi Murata, Kohei Nishitani, Ryu Watanabe, Wataru Yamamoto, Masao Tanaka, Akio Morinobu, Hiromu Ito, Shuichi Matsuda, Ritei Uehara
Pain catastrophizing hinders Disease Activity Score 28 - erythrocyte sedimentation rate remission of rheumatoid arthritis in patients with normal C-reactive protein levels. International journal of rheumatic diseases 24 (12) (2021)
Hinako Kondo, Ryu Watanabe, Soshi Okazaki, Kaori Kuriyama, Tetsuro Ochi, Gen Yamada, Akira Sugiura, Hiromu Chiba, Akira Tsukada, Shinji Taniuchi, Takehiko Igarashi, Masataka Kudo, Hideo Harigae, Hiroshi Fujii
JAK2 mutation-positive polycythaemia vera associated with IgA vasculitis and nephrotic syndrome: a case report. Modern rheumatology case reports 4 (2) (2020)
Ryu Watanabe
JAK inhibitors as promising agents for refractory Takayasu arteritis. Annals of the rheumatic diseases (2020)
Ryu Watanabe
High incidence of antiresorptive agent-related osteonecrosis of the jaw in patients with rheumatoid arthritis. Journal of bone and mineral metabolism 38 (5) (2020)
Ryu Watanabe
CD4+ T Cells as Key Players in the Immunopathology of Takayasu Arteritis: Comment on the Article by. Arthritis & rheumatology (Hoboken, N.J.) 72 (4) (2020)
Ryu Watanabe, Motomu Hashimoto, Akio Morinobu
Correspondence on 'The use of tocilizumab and tofacitinib in patients with resolved hepatitis B infection: a case series'. Annals of the rheumatic diseases (2020)
Ryu Watanabe, Motomu Hashimoto
Elucidation of disease mechanisms underlying rheumatic immune-related adverse events may lead to novel therapeutic strategies for autoimmune diseases. Annals of the rheumatic diseases (2020)

Ryu Watanabe.css-eqlu8i{font-size:small;padding-left:4px;} (R Watanabe)

Publication Activity (10 Years)

Top Topics

Top Venues

Ryu Watanabe (R Watanabe)